182 related articles for article (PubMed ID: 28730628)
1. Acute hepatic porphyria and cancer risk: a nationwide cohort study.
Baravelli CM; Sandberg S; Aarsand AK; Nilsen RM; Tollånes MC
J Intern Med; 2017 Sep; 282(3):229-240. PubMed ID: 28730628
[TBL] [Abstract][Full Text] [Related]
2. Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals.
Lissing M; Vassiliou D; Floderus Y; Harper P; Bottai M; Kotopouli M; Hagström H; Sardh E; Wahlin S
J Intern Med; 2022 Jun; 291(6):824-836. PubMed ID: 35112415
[TBL] [Abstract][Full Text] [Related]
3. Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals.
Lissing M; Vassiliou D; Floderus Y; Harper P; Yan J; Hagström H; Sardh E; Wahlin S
J Inherit Metab Dis; 2023 Mar; 46(2):286-299. PubMed ID: 36546345
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in acute hepatic porphyrias: A Damocles Sword.
Peoc'h K; Manceau H; Karim Z; Wahlin S; Gouya L; Puy H; Deybach JC
Mol Genet Metab; 2019 Nov; 128(3):236-241. PubMed ID: 30413387
[TBL] [Abstract][Full Text] [Related]
5. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
Wang B; Bonkovsky HL; Lim JK; Balwani M
Gastroenterology; 2023 Mar; 164(3):484-491. PubMed ID: 36642627
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of acute attacks, chronic symptoms, and long-term complications among patients with acute hepatic porphyria in Japan: a real-world claims database study.
Horie Y; Yasuoka Y; Adachi T
Orphanet J Rare Dis; 2023 Dec; 18(1):384. PubMed ID: 38066651
[TBL] [Abstract][Full Text] [Related]
7. Sick leave, disability, and mortality in acute hepatic porphyria: a nationwide cohort study.
Baravelli CM; Aarsand AK; Sandberg S; Tollånes MC
Orphanet J Rare Dis; 2020 Feb; 15(1):56. PubMed ID: 32085780
[TBL] [Abstract][Full Text] [Related]
8. The incidence of inherited porphyrias in Europe.
Elder G; Harper P; Badminton M; Sandberg S; Deybach JC
J Inherit Metab Dis; 2013 Sep; 36(5):849-57. PubMed ID: 23114748
[TBL] [Abstract][Full Text] [Related]
9. The clinical importance of early acute hepatic porphyria diagnosis: a national cohort.
Edel Y; Mamet R; Cohen S; Shepshelovich D; Levi A; Sagy I
Intern Emerg Med; 2021 Jan; 16(1):133-139. PubMed ID: 32372331
[TBL] [Abstract][Full Text] [Related]
10. PICO questions and DELPHI methodology for improving the management of patients with acute hepatic porphyria.
Riera-Mestre A; García Morillo JS; Castelbón Fernández J; Hernández-Contreras ME; Aguilera Peiró P; Jacob J; Martínez Valle F; Guillén-Navarro E; Morales-Conejo M
Rev Clin Esp (Barc); 2024 May; 224(5):272-280. PubMed ID: 38642893
[TBL] [Abstract][Full Text] [Related]
11. High risk of primary liver cancer in a cohort of 179 patients with Acute Hepatic Porphyria.
Sardh E; Wahlin S; Björnstedt M; Harper P; Andersson DE
J Inherit Metab Dis; 2013 Nov; 36(6):1063-71. PubMed ID: 23344888
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular Carcinoma in Acute Hepatic Porphyrias: Results from the Longitudinal Study of the U.S. Porphyrias Consortium.
Saberi B; Naik H; Overbey JR; Erwin AL; Anderson KE; Bissell DM; Bonkovsky HL; Phillips JD; Wang B; K Singal A; M McGuire B; Desnick RJ; Balwani M
Hepatology; 2021 May; 73(5):1736-1746. PubMed ID: 32681675
[TBL] [Abstract][Full Text] [Related]
13. Expert consensus statement on acute hepatic porphyria in Belgium.
Gilles A; Vermeersch S; Vermeersch P; Wolff F; Cotton F; Tilleux S; Cassiman D
Acta Clin Belg; 2022 Aug; 77(4):735-741. PubMed ID: 34369323
[TBL] [Abstract][Full Text] [Related]
14. Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyria.
Cohen AM; Chamberlin S; Deloughery T; Nguyen M; Bedrick S; Meninger S; Ko JJ; Amin JJ; Wei AJ; Hersh W
PLoS One; 2020; 15(7):e0235574. PubMed ID: 32614911
[TBL] [Abstract][Full Text] [Related]
15. Porphyria cutanea tarda increases risk of hepatocellular carcinoma and premature death: a nationwide cohort study.
Baravelli CM; Sandberg S; Aarsand AK; Tollånes MC
Orphanet J Rare Dis; 2019 Apr; 14(1):77. PubMed ID: 30944007
[TBL] [Abstract][Full Text] [Related]
16. Maternal and fetal outcomes in acute hepatic porphyria: A Swedish National Cohort Study.
Mantel Ä; Vassiliou D; Lissing M; Stephansson O; Wahlin S; Sardh E
J Inherit Metab Dis; 2023 Jul; 46(4):675-686. PubMed ID: 37078226
[TBL] [Abstract][Full Text] [Related]
17. Primary liver cancer, other malignancies, and mortality risks following porphyria: a cohort study in Denmark and Sweden.
Linet MS; Gridley G; Nyrén O; Mellemkjaer L; Olsen JH; Keehn S; Adami HO; Fraumeni JF
Am J Epidemiol; 1999 Jun; 149(11):1010-5. PubMed ID: 10355376
[TBL] [Abstract][Full Text] [Related]
18. Acute hepatic porphyria and maternal health: Clinical and biochemical follow-up of 44 pregnancies.
Vassiliou D; Sardh E
J Intern Med; 2022 Jan; 291(1):81-94. PubMed ID: 34411356
[TBL] [Abstract][Full Text] [Related]
19. A next-generation-sequencing panel for mutational analysis of dominant acute hepatic porphyrias.
Barman-Aksözen J; Suter L; Wegmann F; Meienberg J; Minder AE; Beer M; Komminoth P; Minder EI; Schneider-Yin X
Scand J Clin Lab Invest; 2019 Sep; 79(5):305-313. PubMed ID: 31154864
[TBL] [Abstract][Full Text] [Related]
20. Biochemical Diagnosis of Acute Hepatic Porphyria: Updated Expert Recommendations for Primary Care Physicians.
Anderson KE; Lobo R; Salazar D; Schloetter M; Spitzer G; White AL; Young RM; Bonkovsky HL; Frank EL; Mora J; Tortorelli S
Am J Med Sci; 2021 Aug; 362(2):113-121. PubMed ID: 33865828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]